Smith & Nephew Snats (NY: SNN )

38.80 USD +0.25 (+0.65%)

Official Closing Price Updated: 7:00 PM EDT, Apr 13, 2021 Add to My Watchlist

Price and Volume

Volume	493,000
Open	38.59
Bid (Size)	38.10 (26)
Ask (Size)	39.77 (1)
Prev. Close	38.55
Today's Range	38.59 - 38.91
52wk Range	34.29 - 46.10
Shares Outstanding	N/A
Dividend Yield	1.84%

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Seven million hours of patient data shows that Smith+Nephew's wireless, wearable LEAF™ Patient Monitoring System helps prevent hospital-acquired pressure injuries

April 13, 2021

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announce that its wireless, wearable LEAF Patient Monitoring System has monitored more than 60,000 patients with...

Smith+Nephew adds Movendo Technology's patient rehabilitation solution to Real Intelligence digital ecosystem

March 25, 2021

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces a marketing collaboration with Movendo Technology (Genoa, Italy) that will add personalised robotic patient...

Performance

YTD	-9.70%	-9.70%
1 Month	-0.41%	-0.41%
3 Month	-8.60%	-8.60%
6 Month	-1.42%	-1.42%
1 Year	-1.12%	-1.12%

More News

Smith+Nephew's ALLEVYN™ LIFE Foam Dressings halved change frequency, significantly reduced cost and improved treatment satisfaction in real-world study

March 18, 2021

Net Health Adds Smith+Nephew's RENASYS GO Negative Pressure Wound Therapy System to Net Health® Wound Care Connections Lineup

March 09, 2021

Smith+Nephew's PICO™ Single Use Negative Pressure Wound Therapy System again shown to significantly reduce surgical site complications

January 27, 2021

Smith+Nephew partners with Movemedical to streamline inventory management and improve customer experience

January 12, 2021

Integra LifeSciences Completes the Sale of its Extremity Orthopedics Business to Smith+Nephew

January 04, 2021

New data confirms Smith+Nephew technology as the best performing cementless construct for Total Hip Arthroplasty¹

December 16, 2020

Smith+Nephew announces RI.INSIGHTS - a global data analytics platform designed to advance the standard of care for robotics-assisted joint replacement procedures

December 08, 2020

New data shows Smith+Nephew's NOVOSTITCH™ Meniscal Repair Systems achieve 82.6% success rate for difficult to repair¹ horizontal cleavage tears at two years follow-up

November 17, 2020

Smith+Nephew adds patient selection and care-pathway optimization tools to ARIA Digital Care Management Platform for ASCs

November 05, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.